Chagas drug

Shares of KaloBios Pharmctcls (OTC: KBIOQ) climbed as much as 22 percent Thursday after a WSJ report said the embattled pharma company may still get its hand on the drug used to treat Chagas disease. KaloBios, which filed for bankruptcy in December, was trying to buy the drug when its former...